2.10
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Phio Pharmaceuticals Corporation | PHIO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.22 | -9.48% | 2.10 | 2.0201 | 2.39 | 2.39 | 2.32 | 20:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 2.02 | 2.30 | 0.28 | 12.17% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 343 | 69,865 | $ 2.16 | $ 150,641 | 319,745 | 0.097 - 10.85 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 2,637 | $ 2.10 | USD |
Phio Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 3.90M | 1.86M | $ -7.36M | -66.00 | 0.20 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Phio Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PHIO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.10 | 2.50 | 1.97 | 2.25 | 91,570 | 0.00 | 0.0% |
| 1 Month | 2.77 | 4.30 | 1.5101 | 2.62 | 361,662 | -0.67 | -24.19% |
| 3 Months | 0.1946 | 10.85 | 0.16 | 0.9050717 | 1,009,396 | 1.91 | 979.14% |
| 6 Months | 0.267 | 10.85 | 0.097 | 0.5203003 | 962,406 | 1.83 | 686.52% |
| 1 Year | 0.43 | 10.85 | 0.097 | 0.4993351 | 654,790 | 1.67 | 388.37% |
| 3 Years | 0.39 | 10.85 | 0.097 | 0.4765033 | 610,930 | 1.71 | 438.46% |
| 5 Years | 0.39 | 10.85 | 0.097 | 0.4765033 | 610,930 | 1.71 | 438.46% |
Phio Pharmaceuticals Description
| Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immunooncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The clinical development program of the company includes RXI-109, a sd-rxRNA for the treatment of dermal and ocular scarring, and Samcyprone, for the treatment of warts. The pipeline product of the company includes RXI-109, Immuno-oncology cell therapy, samcyprone, RXI-231, and RXI-185. The pipeline programs focus on dermatology, including cosmetic product development, ophthalmology, and cell-based cancer immunotherapy. |
